News »
20. Februar 2012     Print Print 

Robert Denham appointed to the board of UGL

UGL Limited is very pleased to announce the appointment of Robert E. Denham to its Board as a non-executive director. Mr Denham has more than thirty years’ experience as a lawyer advising clients on strategic and financial issues. Mr Denham is a partner in the US law firm of Munger, Tolles & Olson LLP, having rejoined the firm in 1998 after serving as the Chairman and CEO of Salomon Inc. from 1992 to 1997.

As Chairman and CEO of Salomon Inc., Mr Denham was responsible for the management of a financial services holding company whose principal businesses were investment banking and securities trading, commodities trading and oil refining.

Mr Denham, who is based in Los Angeles USA, is a member of the board of directors of Chevron Corporation, Fomento Economico Mexicano, S.A. de CV, Oaktree Capital Group LLC and The New York Times Company. He also serves as Chairman of the John D. and Catherine T. MacArthur Foundation and the Russell Sage Foundation and is a trustee of Good Samaritan Hospital of Los Angeles.

UGL Chairman, Trevor Rowe AO, said: “Bob brings to UGL significant strategic experience as a director of various global public companies and a wealth of knowledge from his legal and financial expertise. UGL is extremely fortunate to have attracted a director of Bob’s calibre to its Board and we look forward to working with Bob to continue to build on the successes already achieved by UGL.

“The appointment of Bob Denham is a key milestone in the Board’s renewal program and our commitment to identifying and attracting suitably experienced leaders as we continue to expand our international presence. We believe the unique knowledge and guidance Bob will bring to the company will provide unparalleled support to UGL’s evolution as it continues to grow and build its strategic platform globally.” The Board will nominate Robert E. Denham for election as a director at UGL’s 2012 Annual General Meeting.